Michaela Liedtke

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Topics

Multiple Myeloma

Clostridium Difficile

Top Venues

American journal of hematology

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Yaqi Zhao, A Douglas Laird, Kathryn G Roberts, Rolla Yafawi, Hagop Kantarjian, Daniel J DeAngelo, Matthias Stelljes, Michaela Liedtke, Wendy Stock, Nicola Gökbuget, Susan M O'Brien, Elias Jabbour, Ryan D Cassaday, Melanie R Loyd, Scott Olsen, Geoffrey A Neale, Xueli Liu, Erik Vandendries, Anjali S Advani, Charles G Mullighan
Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL. Blood advances 8 (12) (2024)
Yaqi Zhao, A Douglas Laird, Kathryn G Roberts, Rolla Yafawi, Hagop Kantarjian, Daniel J DeAngelo, Matthias Stelljes, Michaela Liedtke, Wendy Stock, Nicola Gökbuget, Susan M O'Brien, Elias Jabbour, Ryan D Cassaday, Melanie R Loyd, Scott Olsen, Geoffrey A Neale, Xueli Liu, Erik Vandendries, Anjali S Advani, Charles G Mullighan
Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL. Blood advances 8 (12) (2024)
Yaqi Zhao, A Douglas Laird, Kathryn G Roberts, Rolla Yafawi, Hagop Kantarjian, Daniel J DeAngelo, Matthias Stelljes, Michaela Liedtke, Wendy Stock, Nicola Gökbuget, Susan M O'Brien, Elias Jabbour, Ryan D Cassaday, Melanie R Loyd, Scott Olsen, Geoffrey A Neale, Xueli Liu, Erik Vandendries, Anjali S Advani, Charles G Mullighan
Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL. Blood advances 8 (12) (2024)
Yaqi Zhao, A Douglas Laird, Kathryn G Roberts, Rolla L Yafawi, Hagop M Kantarjian, Daniel J DeAngelo, Matthias Stelljes, Michaela Liedtke, Wendy Stock, Nicola Gökbuget, Susan M O'Brien, Elias J Jabbour, Ryan D Cassaday, Melanie R Loyd, Scott R Olsen, Geoffrey A Neale, Xueli Liu, Erik Vandendries, Anjali S Advani, Charles G Mullighan
Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL. Blood advances (2024)
Hrishikesh Krishna Srinagesh, Clayton Jackson, Parveen Shiraz, Nikeshan Jeyakumar, Mark P Hamilton, Emily Egeler, Sharon Mavroukakis, Adam Kuo, Juancarlos Cancilla, Bita Sahaf, Neha Agarwal, Alyssa M Kanegai, Anne Marijn Kramer, Sally Arai, Sushma Bharadwaj, Saurabh Dahiya, Hitomi Hosoya, Laura J Johnston, Vanessa E Kennedy, Michaela Liedtke, Robert Lowsky, Lekha Mikkilineni, Robert S Negrin, Andrew R Rezvani, Surbhi Sidana, Judith A Shizuru, Melody Smith, Wen-Kai Weng, Steven A Feldman, Matthew J Frank, Zachary Lee, Mary Tagliaferri, A Mario Q Marcondes, David Bernard Miklos, Crystal L Mackall, Lori S Muffly
A Phase 1 Clinical Trial of NKTR-255 with CD19-22 CAR-T Cell Therapy for Refractory B-cell Acute Lymphoblastic Leukemia. Blood (2024)
Yaqi Zhao, A Douglas Laird, Kathryn G Roberts, Rolla Yafawi, Hagop Kantarjian, Daniel J DeAngelo, Matthias Stelljes, Michaela Liedtke, Wendy Stock, Nicola Gökbuget, Susan M O'Brien, Elias Jabbour, Ryan D Cassaday, Melanie R Loyd, Scott Olsen, Geoffrey A Neale, Xueli Liu, Erik Vandendries, Anjali S Advani, Charles G Mullighan
Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL. Blood advances 8 (12) (2024)
Morie A Gertz, Adam David Cohen, Raymond L Comenzo, Efstathios Kastritis, Heather J Landau, Edward N Libby, Michaela Liedtke, Vaishali Sanchorawala, Stefan Schönland, Ashutosh D Wechalekar, Jeffrey A Zonder, Giovanni Palladini, Jackie Walling, Spencer Guthrie, Christie Nie, Carol Karp, Yuying Jin, Gene G Kinney, Giampaolo Merlini
Birtamimab plus standard of care in light chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial. Blood (2023)
Barry A Paul, Michaela Liedtke, Jack Khouri, Robert M Rifkin, Mitul D Gandhi, Andrew Kin, Moshe Y Levy, Rebecca W Silbermann, Francesca Cottini, Douglas W Sborov, Irwindeep Sandhu, Lyssa Villarreal, Michael Murphy, Lin Gu, Ann Chen, Nishanthan Rajakumaraswamy, Saad Z Usmani
A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma. Future oncology (London, England) (2023)
Yu Rebecca Miao, Kaushik N Thakkar, Can Cenik, Dadi Jiang, Kazue Mizuno, Chenjun Jia, Caiyun Grace Li, Hongjuan Zhao, Anh Diep, Yu Xu, Xin Eric Zhang, Teddy Tat Chi Yang, Michaela Liedtke, Parveen Abidi, Wing-Sze Leung, Albert C Koong, Amato J Giaccia
Developing high-affinity decoy receptors to treat multiple myeloma and diffuse large B cell lymphoma. The Journal of experimental medicine 219 (9) (2022)
Ibrahim Aldoss, Jun Yin, Anna Wall, Krzysztof Mrózek, Michaela Liedtke, David Claxton, Matthew C Foster, Frederick R Appelbaum, Harry P Erba, Mark R Litzow, Martin S Tallman, Richard M Stone, Richard A Larson, Anjali S Advani, Wendy Stock, Selina M Luger
The impact of early PEG-asparaginase discontinuation in young adults with ALL: A post hoc analysis of the C10403 study. Blood advances (2022)
Eli Muchtar, Angela Dispenzieri, Brendan Wisniowski, Giovanni Palladini, Paolo Milani, Giampaolo Merlini, Stefan O Schönland, Kaya Veelken, Ute Hegenbart, Susan M Geyer, Shaji K Kumar, Efstathios Kastritis, Meletios- Athanasios Dimopoulos, Michaela Liedtke, Ronald Witteles, Vaishali Sanchorawala, Raphael Szalat, Heather J Landau, Erica Petrlik, Suzanne Lentzch, Alexander Coltoff, Joan Bladé, Maria Teresa Cibeira, Oliver Cohen, Darren Foard, Ashutosh Wechalekar, Morie A Gertz
Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Matthew J Wieduwilt, Jun Yin, Meir Wetzler, Geoffrey L Uy, Bayard L Powell, Jonathan E Kolitz, Michaela Liedtke, Wendy Stock, Jan H Beumer, Ryan J Mattison, Elizabeth Storrick, Susan M Christner, Lionel D Lewis, Steven Devine, Richard M Stone, Richard A Larson
Dasatinib and dexamethasone followed by hematopoietic cell transplantation for adults with Ph-positive ALL. Blood advances 5 (22) (2021)
Lori S Muffly, Vandana Sundaram, Connie Chen, Ilana Yurkiewicz, Eric Kuo, Sarah Burnash, Jay Y Spiegel, Sally Arai, Matthew J Frank, Laura J Johnston, Robert Lowsky, Everett H Meyer, Robert S Negrin, Andrew R Rezvani, Surbhi Sidana, Parveen Shiraz, Judith A Shizuru, Wen-Kai Weng, Michaela Liedtke, Hyma T Vempaty, David Bernard Miklos
Concordance of peripheral blood and bone marrow measurable residual disease in adult acute lymphoblastic leukemia. Blood advances 5 (16) (2021)
Robert Frank Cornell, Parameswaran Hari, Shijie Tang, Noa Biran, Natalie Callander, Ajai Chari, Saurabh Chhabra, Mark A Fiala, Zhubin Gahvari, Ujjawal Gandhi, Kelly Godby, Ridhi Gupta, Sundar Jagannath, Megan Jagosky, Yubin Kang, Ankit Kansagra, Michael Kauffman, Saranya Kodali, Shaji K Kumar, Arjun Lakshman, Michaela Liedtke, Sagar Lonial, Xiwen Ma, Ehsan Malek, Joshua Mansour, Elizabeth F McGehee, Amarendra Neppalli, Barry Paul, Paul Richardson, Emma C Scott, Sharon Shacham, Jatin Shah, David S Siegel, Elvira Umyarova, Saad Z Usmani, William Varnado, Ravi Vij, Luciano Costa
Overall survival of patients with triple-class refractory multiple myeloma treated with selinexor plus dexamethasone vs standard of care in MAMMOTH. American journal of hematology 96 (1) (2020)
Elias J Jabbour, Anjali S Advani, Matthias Stelljes, Wendy Stock, Michaela Liedtke, Nicola Gökbuget, Giovanni Martinelli, Susan M O'Brien, Jane Liang White, Tao Wang, M Luisa Paccagnella, Barbara Sleight, Erik Vandendries, Daniel J DeAngelo, Hagop M Kantarjian
Prognostic implications of cytogenetics in adults with acute lymphoblastic leukemia treated with inotuzumab ozogamicin. American journal of hematology 94 (4) (2019)
Paul Gerard Richardson, Craig C Hofmeister, Cara A Rosenbaum, Myo Htut, David H Vesole, Jesus G Berdeja, Michaela Liedtke, Ajai Chari, Stephen D Smith, Daniel Lebovic, Noopur Raje, Catriona Byrne, Eileen Liao, Neeraj Gupta, Alessandra Di Bacco, Jose Estevam, Deborah Berg, Rachid Baz
Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma. British journal of haematology 182 (2) (2018)
Cynthia L Gong, Ann L Studdert, Michaela Liedtke
Daratumumab vs pomalidomide for the treatment of relapsed/refractory multiple myeloma: A cost-effectiveness analysis. American journal of hematology 94 (3) (2018)
Erik Eckhert, Ronald Witteles, Gregory Kaufman, Richard Lafayette, Sally Arai, Stanley Schrier, Michelle O'Shaughnessy, Michaela Liedtke
Grading cardiac response in AL amyloidosis: implications for relapse and survival. British journal of haematology 186 (1) (2018)
Shira Dinner, Tamara J Dunn, Elizabeth Price, Steven E Coutré, Jason Gotlib, Caroline Berube, Gregory P Kaufman, Bruno C Medeiros, Michaela Liedtke
A phase I, open-label, dose-escalation study of amrubicin in combination with lenalidomide and weekly dexamethasone in previously treated adults with relapsed or refractory multiple myeloma. International journal of hematology 108 (3) (2018)
Gregory P Kaufman, Stanley L Schrier, Richard A Lafayette, Sally Arai, Ronald M Witteles, Michaela Liedtke
Daratumumab yields rapid and deep hematologic responses in patients with heavily pretreated AL amyloidosis. Blood 130 (7) (2017)